Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium chloride + dextrose is a sterile, nonpyrogenic intravenous solution used for fluid and electrolyte replenishment and caloric supply. It combines potassium chloride, the primary cation of the intracellular fluid, with dextrose (glucose monohydrate), a simple carbohydrate that serves as a readily available source of energy. The solution is indicated for patients requiring the replacement of water and electrolytes, specifically for the prevention and treatment of potassium deficiency (hypokalemia), and to provide a source of calories when oral intake is insufficient. Potassium is essential for the maintenance of intracellular tonicity, transmission of nerve impulses, and contraction of cardiac, skeletal, and smooth muscles. Dextrose provides metabolic energy and helps restore blood glucose levels. This combination drug is a cornerstone of parenteral fluid therapy and is manufactured by multiple generic pharmaceutical and medical device companies, including ICU Medical and Baxter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + dextrose.